ask="9.33"
ask_size="600"
average_daily_volume="249435"
bid="5.15"
bid_size="100"
book_value="3.42"
change="+0.26"
change_from_200_day_moving_average="-0.36"
change_from_50_day_moving_average="0.24"
change_from_52_week_high="-4.66"
change_From_52_week_low="2.25"
change_in_percent="+3.43%"
close="7.84"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.07"
ebitda="-1.40M"
eps_estimate_current_year="-2.94"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-2.63"
ex_dividend_date="N/A"
float_shares="5020000"
high="7.90"
high_52_weeks="12.50"
last_trade_date="2/3/2017"
last_trade_price="7.84"
last_trade_size="246"
last_trade_time="4:00pm"
low="7.63"
low_52_weeks="5.59"
market_capitalization="95.36M"
moving_average_200_day="8.20"
moving_average_50_day="7.60"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.80"
open="7.63"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-4.34%"
percent_change_from_50_day_moving_average="+3.19%"
percent_change_from_52_week_high="-37.28%"
percent_change_from_52_week_low="+40.25%"
previous_close="7.58"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.21"
price_per_sales="1.34"
revenue="68.73M"
shares_outstanding="12163000"
short_ratio="1.54"
stock_exchange="NCM"
symbol="REPH"
volume="42186"
weeks_range_52="5.59 - 12.50"
